Novartis AG (ADR) (NVS): Make A Move Suave, Novartis buy [Pfizer Inc., Amgen

Novartis AG (ADR) (NVS): Make A Move Suave, Novartis buy [Pfizer Inc., Amgen ... Novartis increased its sales forecast for the full year due to th...


Novartis AG (ADR) (NVS): Make A Move Suave, Novartis buy [Pfizer Inc., Amgen
Novartis increased its sales forecast for the full year due to the expected delay in generic competition for its blockbuster drug blood pressure, Diovan. Last year, the company lost the U.S. patent rights for Diovan. This medication helped Novartis …
Read more on Seeking Alpha


Leave a Reply